Skip to main content
. Author manuscript; available in PMC: 2018 Aug 30.
Published in final edited form as: Int J Pharm. 2017 Jun 17;529(1-2):32–43. doi: 10.1016/j.ijpharm.2017.06.042

Figure 2.

Figure 2

In vitro release of CIP obtained across Spectra/Por® membrane (MWCO: 3.5 KDa) from CIP loaded PEGylated NLCs (PEG(2K)-CIP-NLCs), 0.3% w/v CIP ophthalmic Solution, and CIP-NLCs (DSPE-CIP-NLCs) obtained using Valia-Chien cells at 34°C. (Dose: 500 μL; 1500 μg).